Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial

DOI Full Paper Access

176

Citations

13

References

2020

Year

Florence Roufosse, Jean‐Emmanuel Kahn, Marc E. Rothenberg, Andrew J. Wardlaw, Amy D. Klion, Suyong Yun Kirby, M Gilson, Jane H. Bentley, Eric Bradford, Steven W. Yancey,

Journal of Allergy and Clinical Immunology

Abstract

Compared with placebo, mepolizumab significantly reduced the occurrence of flares in patients with HES, with no new safety signals identified.

References

	Year	Citations

Page 1